The clinical study on the safety and effectiveness of Apatinib Mesylate in locally advanced head and neck soft tissue sarcoma with the induction chemotherapy treatment
Latest Information Update: 06 Dec 2017
At a glance
- Drugs Rivoceranib (Primary)
- Indications Head and neck cancer; Soft tissue sarcoma
- Focus Therapeutic Use
- 06 Dec 2017 New trial record